Zobrazeno 1 - 10
of 1 087
pro vyhledávání: '"A. van den Ham"'
Autor:
Kristin M. Van Den Ham, Layne K. Bower, Shanping Li, Hernan Lorenzi, Safiatou Doumbo, Didier Doumtabe, Kassoum Kayentao, Aissata Ongoiba, Boubacar Traore, Peter D. Crompton, Nathan W. Schmidt
Publikováno v:
Nature Communications, Vol 15, Iss 1, Pp 1-16 (2024)
Abstract Malaria is a major public health problem, but many of the factors underlying the pathogenesis of this disease are not well understood, including protection from the development of febrile symptoms, which is observed in individuals residing i
Externí odkaz:
https://doaj.org/article/ad6c62eb6c4f4c5f9e2bbb33c26090bc
Autor:
Francine Brinkhuis, Elaine Julian, Hendrika van den Ham, Fabrizio Gianfrate, Valentina Strammiello, Michael Berntgen, Mira Pavlovic, Peter Mol, Jürgen Wasem, Walter Van Dyck, Antonella Cardone, Christian Dierks, Anja Schiel, Renato Bernardini, Oriol Solà-Morales, Jörg Ruof, Wim Goettsch
Publikováno v:
Health Research Policy and Systems, Vol 22, Iss 1, Pp 1-12 (2024)
Abstract Background The European Regulation on Health Technology Assessment (EU HTA R), effective since January 2022, aims to harmonize and improve the efficiency of common HTA across Member States (MS), with a phased implementation from January 2025
Externí odkaz:
https://doaj.org/article/660c1c179a5f4b32bace34cbb01905ab
Autor:
Iris R. Joosse, Hendrika A. van den Ham, Aukje K. Mantel-Teeuwisse, Velisha A. Perumal-Pillay, Fatima Suleman
Publikováno v:
Journal of Pharmaceutical Policy and Practice, Vol 17, Iss 1 (2024)
Background We sought to identify what barriers and facilitators determine current perceived access to childhood cancer care in South Africa through in-depth interviews with stakeholders in South Africa’s public and private sectors.Methods Qualitati
Externí odkaz:
https://doaj.org/article/dc634301bd164c87828ed43d0b76bdd0
Publikováno v:
Journal of Pharmaceutical Policy and Practice, Vol 17, Iss 1 (2024)
ABSTRACTBackground This study explored the treatment-related, financial and psychological experiences of caregivers during cancer treatment of their children in South Africa’s (SA) public and private sectors.Methods In this exploratory study, three
Externí odkaz:
https://doaj.org/article/76b4c41215f74f1490a0d2989df75782
Publikováno v:
Journal of Pharmaceutical Policy and Practice, Vol 17, Iss 1 (2024)
Background: The WHO Essential Medicine List for Children was released on the 30th anniversary of the general Essential Medicine List in 2007, to recognise special needs for medicines in children, and to promote the inclusion of paediatric medicines i
Externí odkaz:
https://doaj.org/article/a43843e6a2d84f35a6a7775d182056b7
Publikováno v:
BMC Research Notes, Vol 17, Iss 1, Pp 1-7 (2024)
Abstract Objective Despite global recognition that access to medicines is shaped by various interacting processes within a health system, a suitable analytical framework for identifying barriers and facilitators from a system’s perspective was need
Externí odkaz:
https://doaj.org/article/13478b272c0a447e8c78789351402ee7
Autor:
Gaby I. Ooms, Mohammed A. Usman, Tim Reed, Hendrika A. van den Ham, Aukje K. Mantel-Teeuwisse
Publikováno v:
BMC Health Services Research, Vol 24, Iss 1, Pp 1-10 (2024)
Abstract Background Access to anaesthesia and surgical care is a major problem for people living in Sub-Saharan Africa. In this region, ketamine is critical for the provision of anaesthesia care. However, efforts to control ketamine internationally a
Externí odkaz:
https://doaj.org/article/a3b953fc425a4817a7f64cb37759f458
Autor:
Brinkhuis, Francine, Ruof, Jörg, van den Ham, Hendrika, Gianfrate, Fabrizio, Strammiello, Valentina, Berntgen, Michael, Pavlovic, Mira, Mol, Peter, Wasem, Jürgen, Van Dyck, Walter, Cardone, Antonella, Dierks, Christian, Schiel, Anja, Solà-Morales, Oriol, Goettsch, Wim, Julian, Elaine
Publikováno v:
In Health Policy and Technology November 2024 13(5)
Autor:
Davies, Lisa E.M., van den Ham, Hendrika A., Schellekens, Arnt F.A., Philbert, Daphne, Bouvy, Marcel L.
Publikováno v:
In Patient Education and Counseling February 2025 131
Autor:
Judith Wienke, Maaike Nederend, Jeanette Leusen, Marjolein Stip, Marco Jansen, Chilam Chan, Femke van den Ham, Geert van Tetering, Elsemieke Passchier
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 12, Iss 5 (2024)
Background Approximately half of the neuroblastoma patients develop high-risk neuroblastoma. Current treatment involves a multimodal strategy, including immunotherapy with dinutuximab (IgG ch14.18) targeting GD2. Despite achieving promising results,
Externí odkaz:
https://doaj.org/article/b79a80b51faa484288067e852353cc9d